Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
- Dilan A. Patel
- , Fei Wan
- , Kathryn Trinkaus
- , Daniel G. Guy
- , Natasha Edwin
- , Marcus Watkins
- , Nancy L. Bartlett
- , Amanda Cashen
- , Todd A. Fehniger
- , Armin Ghobadi
- , Neha Mehta Shah
- , Brad S. Kahl
- Division of Public Health Sciences
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Immunology
- Bursky Center for Human Immunology and Immunotherapy
- Section of Hematological Malignancies
- Division of Oncology
Research output: Contribution to journal › Article › peer-review
1
Link opens in a new tab
Scopus
citations